Bioengineered System for High Throughput Screening of Kv1 Ion Channel Blockers
Open Access
- 16 November 2021
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 8 (11) , 187
Abstract
Screening drug candidates for their affinity and selectivity for a certain binding site is a crucial step in developing targeted therapy. Here, we created a screening assay for receptor binding that can be easily scaled up and automated for the high throughput screening of Kv channel blockers. It is based on the expression of the KcsA-Kv1 hybrid channel tagged with a fluorescent protein in the E. coli membrane. In order to make this channel accessible for the soluble compounds, E. coli were transformed into spheroplasts by disruption of the cellular peptidoglycan envelope. The assay was evaluated using a hybrid KcsA-Kv1.3 potassium channel tagged with a red fluorescent protein (TagRFP). The binding of Kv1.3 channel blockers was measured by flow cytometry either by using their fluorescent conjugates or by determining the ability of unconjugated compounds to displace fluorescently labeled blockers with a known affinity. A fraction of the occupied receptor was calculated with a dedicated pipeline available as a Jupyter notebook. Measured binding constants for agitoxin-2, charybdotoxin and kaliotoxin were in firm agreement with the earlier published data. By using a mid-range flow cytometer with manual sample handling, we measured and analyzed up to ten titration curves (eight data points each) in one day. Finally, we considered possibilities for multiplexing, scaling and automation of the assay.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (Theme No. 0101-2019-0015)
This publication has 32 references indexed in Scilit:
- Flow cytometry of fluorescent proteinsMethods, 2012
- Signaling from the Living Plasma MembraneCell, 2011
- Kv1.5 in the Immune System: the Good, the Bad, or the Ugly?Frontiers in Physiology, 2010
- Voltage-gated potassium channels as therapeutic targetsNature Reviews Drug Discovery, 2009
- Recombinant Kv Channels at the Membrane of Escherichia coli Bind Specifically Agitoxin2Journal of Neuroimmune Pharmacology, 2008
- Time, the forgotten dimension of ligand binding teachingBiochemistry and Molecular Biology Education, 2006
- Toxin-induced conformational changes in a potassium channel revealed by solid-state NMRNature, 2006
- Generating a High Affinity Scorpion Toxin Receptor in KcsA-Kv1.3 Chimeric Potassium ChannelsJournal of Biological Chemistry, 2000
- Purification and Characterization of Three Inhibitors of Voltage-Dependent K+ Channels from Leiurus Quinquestriatus var. Hebraeus VenomBiochemistry, 1994
- Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes.Journal of General Physiology, 1989